Overview: A/Prof. Maljevic’s research will investigate the impact of SYNGAP1 variants on early neurodevelopment using patient-derived induced pluripotent stem cells (iPSCs). This study aims to understand the correlation between early neurogenesis disruption and the severity of clinical presentations, potentially accelerating the development of targeted therapies.
“We are grateful to the Syngap Research Fund Australia and the Epilepsy Foundation for supporting our work on this rare and devastating disorder. This grant empowers us to delve deeper into understanding the disease and paves the way for developing precision therapies that could transform lives. We are honoured to be part of this meaningful journey.” Associate Professor Snezana Maljevic.